RETRACTED: The profile of the key pro-inflammatory cytokines in the serum of patients with CD and their association with the disease severity and activity (Retracted article. See vol. 23, 2023)

被引:3
作者
Al Qteishat, Ahmed [1 ]
Kirov, Kiril [2 ]
Bokov, Dmitry [3 ,4 ]
机构
[1] Univ Nizwa, Dept Biol Sci & Chem, Birkat Al Mouz 33, Nizwa 616, Oman
[2] Med Univ Pleven, Res Inst, Sv Kliment Ohridski Str 1, Pleven 5800, Bulgaria
[3] Sechenov First Moscow State Med Univ, Inst Pharm, Trubetskaya Str 8-2, Moscow 119991, Russia
[4] Fed Res Ctr Nutr Biotechnol & Food Safety, Lab Food Chem, Moscow, Russia
关键词
Crohn's disease; Pathogenesis; Cytokines; Immune system; Blood; CROHNS-DISEASE; RISK-FACTORS; MANAGEMENT;
D O I
10.1186/s12876-022-02562-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The epidemiology of Crohn's disease (CD) has changed over the past decades, demonstrating a trend toward increased prevalence in developing countries, while in developed countries, its incidence has stabilized. The study aimed to examine the profile of the key pro-inflammatory cytokines in the serum of patients with CD and establish their association with the severity and activity of the disease. Methods A total of 61 patients (29 women (47.5%), 32 men (52.5%) aged from 18 to 40 years (mean age (30.42 +/- 2.51) years) with the verified diagnosis of CD in the active phase were examined. The control group consisted of 30 healthy people of corresponding age. Results CD is characterized by a reliable increase of pro-inflammatory cytokines in blood compared to healthy people: tumor necrosis factor-alpha (TNF-alpha) - by 4.45 times (137.46 +/- 9.72 vs. 30.88 +/- 2.08 pg/ml in healthy people, p < 0,001), interleukin-1 alpha (IL-1 alpha) - by 5.08 times (51.55 +/- 4.36 vs. 10.14 +/- 0.93 pg/ml, p < 0.001), interleukin-6 (IL-6) - by 2.16 times (20.03 +/- 1.81 vs. 9.27 +/- 0.52 pg/ml, p < 0.001), interleukin-8 (IL-8) - by 2.04 times (25.74 +/- 2.05 vs. 12.62 +/- 1.16 pg/ml, p < 0.001), and interferon-gamma (IFN-gamma) - by 5.30 times (208.63 +/- 14.29 vs. 39.35 +/- 2.40 pg/ml, p < 0.001). The authors have established direct correlations between the Crohn's disease activity index and blood content of TNF-alpha (r = 0.84, p < 0.013), INF-gamma (r = 0.61, p < 0.028); between TNF-alpha and INF-gamma content (r = 0.67, p < 0.023), IL-1 alpha (r = 0.49, p < 0.042), IL-6 (r = 0.40, p < 0.045), and IL-8 (r = 0.51, p < 0.033); INF-gamma and IL-1 alpha (r = 0.53, p < 0.040), IL-6 (r = 0.37, p < 0.039), IL-8 (r = 0.44, p < 0.040). Conclusions Patients with CD were found to have multiple cytokines (TNF-alpha, IL-1 alpha, IL-6, IL-8, and IFN-gamma,). The content of cytokines correlated positively with the CD activity index.
引用
收藏
页数:8
相关论文
共 28 条
[1]   Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century [J].
Ananthakrishnan, Ashwin N. ;
Kaplan, Gilaad G. ;
Ng, Siew C. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (06) :1252-1260
[2]  
Bala N, 2022, ETDHR V9, V9, P163
[3]   Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients [J].
Bertani, Lorenzo ;
Baglietto, Laura ;
Antonioli, Luca ;
Fornai, Matteo ;
Tapete, Gherardo ;
Albano, Eleonora ;
Ceccarelli, Linda ;
Mumolo, Maria Gloria ;
Pellegrini, Carolina ;
Lucenteforte, Ersilia ;
de Bortoli, Nicola ;
Bellini, Massimo ;
Marchi, Santino ;
Blandizzi, Corrado ;
Costa, Francesco .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (07) :1296-1305
[4]   Advances in understanding the role of cytokines in inflammatory bowel disease [J].
Bevivino, Gerolamo ;
Monteleone, Giovanni .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (09) :907-915
[5]   Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study [J].
Biancone, Livia ;
Zuzzi, Sara ;
Ranieri, Micaela ;
Petruzziello, Carmelina ;
Calabrese, Emma ;
Onali, Sara ;
Ascolani, Marta ;
Zorzi, Francesca ;
Condino, Giovanna ;
Iacobelli, Simona ;
Pallone, Francesco .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (05) :578-587
[6]  
Chavez-Alvarez S, 2016, GAC MED MEX, V152, P622
[7]   Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial [J].
de Jong, Marin J. ;
Boonen, Annelies ;
van der Meulen-de Jong, Andrea E. ;
Romberg-Camps, Marielle J. ;
van Bodegraven, Ad A. ;
Mahmmod, Nofel ;
Markus, Tineke ;
Dijkstra, Gerard ;
Winkens, Bjorn ;
van Tubergen, Astrid ;
Masclee, Ad ;
Jonkers, Daisy M. ;
Pierik, Marie J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (08) :1744-1752
[8]   Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease [J].
Friedrich, Matthias ;
Pohin, Mathilde ;
Powrie, Fiona .
IMMUNITY, 2019, 50 (04) :992-1006
[9]   3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management [J].
Gomollon, Fernando ;
Dignass, Axel ;
Annese, Vito ;
Tilg, Herbert ;
Van Assche, Gert ;
Lindsay, James O. ;
Peyrin-Biroulet, Laurent ;
Cullen, Garret J. ;
Daperno, Marco ;
Kucharzik, Torsten ;
Rieder, Florian ;
Almer, Sven o ;
Armuzzi, Alessandro ;
Harbord, Marcus ;
Langhorst, Jost ;
Sans, Miquel ;
Chowers, Yehuda ;
Fiorino, Gionata ;
Juillerat, Pascal ;
Mantzaris, Gerassimos J. ;
Rizzello, Fernando ;
Vavricka, Stephan ;
Gionchetti, Paolo .
JOURNAL OF CROHNS & COLITIS, 2017, 11 (01) :3-25
[10]   Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018 [J].
King, Dominic ;
Reulen, Raoul C. ;
Thomas, Tom ;
Chandan, Joht Singh ;
Thayakaran, Rasiah ;
Subramanian, Anuradhaa ;
Gokhale, Krishna ;
Bhala, Neeraj ;
Nirantharakumar, Krishnarajah ;
Adderley, Nicola J. ;
Trudgill, Nigel .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (10) :922-934